RAPT - Company ID 0001673772
The table below shows RAPT Therapeutics, Inc.'s balance sheet line items across its last 6 fiscal years, exactly as reported in the company's audited annual filings. All figures are in US dollars; negative values appear in red.
| Line item | FY 2024 | FY 2023 | FY 2022 | FY 2021 | FY 2020 | FY 2019 |
|---|---|---|---|---|---|---|
| Cash & equivalents | $169.74M | $47.48M | $38.95M | $24.03M | $24.92M | $77.38M |
| Short-term investments | $61.32M | $111.38M | $210.12M | $165.63M | $86.59M | - |
| Receivables | - | - | - | - | - | - |
| Inventory | - | - | - | - | - | - |
Data parsed from SEC EDGAR XBRL filings. See the full market cap rankings.
| Total current assets |
| $235.24M |
| $161.78M |
| $252.69M |
| $192.97M |
| $115.60M |
| $80.51M |
| Property, plant & equipment | $1.37M | $2.45M | $2.54M | $2.74M | $2.98M | $3.71M |
| Goodwill | - | - | - | - | - | - |
| Total assets | $240.32M | $173.33M | $266.21M | $198.64M | $118.97M | $84.60M |
| Accounts payable | $1.27M | $5.18M | $3.37M | $2.00M | $2.38M | $1.14M |
| Total current liabilities | $48.35M | $21.84M | $14.22M | $9.60M | $11.74M | $9.26M |
| Long-term debt | - | - | - | - | - | - |
| Total liabilities | $50.42M | $26.29M | $21.04M | $12.26M | $14.79M | - |
| Retained earnings | -$614.55M | -$484.68M | -$367.88M | -$284.05M | -$214.84M | -$161.95M |
| Total equity | $189.90M | $147.03M | $245.17M | $186.38M | $104.18M | $73.12M |